{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:32:59Z","timestamp":1790019179362,"version":"4.0.1"},"reference-count":140,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jaip.2024.03.010","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T05:20:16Z","timestamp":1710134416000},"page":"1727-1737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Detecting Changes in Mast Cell Numbers Versus Activation in Human Disease: A Roadblock for Current Biomarkers?"],"prefix":"10.1016","volume":"12","author":[{"given":"Cem","family":"Akin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Siebenhaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua B.","family":"Wechsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford A.","family":"Youngblood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4121-481X","authenticated-orcid":false,"given":"Marcus","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.03.010_bib1","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41577-021-00622-y","article-title":"Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases","volume":"22","author":"Kolkhir","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/all.14881","article-title":"The ingenious mast cell: contemporary insights into mast cell behavior and function","volume":"77","author":"Dahlin","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.03.010_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000500088","article-title":"Physiological roles of mast cells: collegium internationale allergologicum update 2019","volume":"179","author":"Varricchi","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ni1158","article-title":"Mast cells in the development of adaptive immune responses","volume":"6","author":"Galli","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3389\/fimmu.2019.00494","article-title":"Biomarkers in human anaphylaxis: a critical appraisal of current evidence and perspectives","volume":"10","author":"Beck","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/all.14065","article-title":"Novel aspects of mast cell and basophil function: highlights from the 9th meeting of the European Mast Cell and Basophil Research Network (EMBRN)\u2014a Marcus Wallenberg symposium","volume":"75","author":"Hallgren","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.03.010_bib7","first-page":"131","article-title":"Novel strategies to target mast cells in disease","volume":"13","author":"Paivandy","year":"2021","journal-title":"J\u00a0Innate Immun"},{"key":"10.1016\/j.jaip.2024.03.010_bib8","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal","volume":"5","author":"Valent","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.jaip.2024.03.010_bib9","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.6004\/jnccn.2018.0088","article-title":"Systemic mastocytosis, version 2.2019, NCCN clinical practice guidelines in oncology","author":"Gotlib","year":"2018","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.jaip.2024.03.010_bib10","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM198706253162603","article-title":"Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis","volume":"316","author":"Schwartz","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.03.010_bib11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000059404","article-title":"Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease","volume":"128","author":"Sperr","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1182\/hematology.2022000366","article-title":"How to evaluate the patient with a suspected mast cell disorder and how\/when to manage symptoms","volume":"2022","author":"Akin","year":"2022","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jaip.2024.03.010_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ad.2015.09.007","article-title":"Update on mastocytosis (part 1): pathophysiology, clinical features, and diagnosis [in English, Spanish]","volume":"107","author":"Aza\u00f1a","year":"2016","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"key":"10.1016\/j.jaip.2024.03.010_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.iac.2013.09.001","article-title":"Mastocytosis","volume":"34","author":"Carter","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.03.010_bib15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/ACI.0b013e3283036a90","article-title":"Understanding the mechanisms of anaphylaxis","volume":"8","author":"Peavy","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World allergy organization anaphylaxis guidance 2020","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2024.03.010_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2017.06.003","article-title":"The pathophysiology of anaphylaxis","volume":"140","author":"Reber","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/all.15850","article-title":"Mast cell silencing: a novel therapeutic approach for urticaria and other mast cell-mediated diseases","volume":"79","author":"Metz","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.03.010_bib19","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/bjd.13621","article-title":"Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous (\u2018idiopathic\u2019) urticaria","volume":"172","author":"Kay","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2024.03.010_bib20","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1398-9995.2011.02570.x","article-title":"Basophil recruitment and activation in inflammatory skin diseases","volume":"66","author":"Ito","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.03.010_bib21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00000372-198912000-00003","article-title":"Incidence of leukocytoclastic vasculitis in chronic idiopathic urticaria. Study of 100 cases","volume":"11","author":"Peteiro","year":"1989","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaip.2024.03.010_bib22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000023902","article-title":"Differential endothelial adhesion molecule expression in early and late whealing reactions","volume":"115","author":"Haas","year":"1998","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/imr.12632","article-title":"The role and relevance of mast cells in urticaria","volume":"282","author":"Church","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaip.2024.03.010_bib24","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA(2)LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.03.010_bib25","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.jaci.2016.08.050","article-title":"Autoimmune chronic spontaneous urticaria: what we know and what we do not know","volume":"139","author":"Kolkhir","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib26","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.jaip.2023.02.022","article-title":"Chronic spontaneous urticaria: the role and relevance of autoreactivity, autoimmunity, and autoallergy","volume":"11","author":"Asero","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.010_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaip.2022.11.006","article-title":"Urticaria and angioedema: understanding complex pathomechanisms to facilitate patient communication, disease management, and future treatment","volume":"11","author":"Konstantinou","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.010_bib28","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jaip.2023.02.006","article-title":"Most patients with autoimmune chronic spontaneous urticaria also have autoallergic urticaria, but not vice versa","volume":"11","author":"Xiang","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.010_bib29","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/all.12884","article-title":"The definition, diagnostic testing, and management of chronic inducible urticarias\u2014the EAACI\/GA(2) LEN\/EDF\/UNEV consensus recommendations 2016 update and revision","volume":"71","author":"Magerl","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.03.010_bib30","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jaci.2010.08.050","article-title":"Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-beta1, and increase esophageal smooth muscle contraction","volume":"126","author":"Aceves","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib31","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jaci.2010.12.1118","article-title":"Expression of mast cell-associated genes is upregulated in adult eosinophilic esophagitis and responds to steroid or dietary therapy","volume":"127","author":"Hsu Blatman","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib32","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/j.cgh.2020.08.013","article-title":"Mast cell and eosinophil counts in gastric and duodenal biopsy specimens from patients with and without eosinophilic gastroenteritis","volume":"19","author":"Reed","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2024.03.010_bib33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.14309\/ajg.0000000000000474","article-title":"Mast cell infiltration is associated with persistent symptoms and endoscopic abnormalities despite resolution of eosinophilia in pediatric eosinophilic esophagitis","volume":"115","author":"Bolton","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2024.03.010_bib34","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jid.2017.12.029","article-title":"The genetics of chronic itch: gene expression in the skin of patients with atopic dermatitis and psoriasis with severe itch","volume":"138","author":"Nattkemper","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2024.03.010_bib35","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.jaci.2022.02.021","article-title":"Mast cells, cortistatin, and its receptor, MRGPRX2, are linked to the pathogenesis of chronic prurigo","volume":"149","author":"Kolkhir","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12890-017-0380-z","article-title":"Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis","volume":"17","author":"Lee","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2024.03.010_bib37","doi-asserted-by":"crossref","first-page":"L619","DOI":"10.1152\/ajplung.00305.2014","article-title":"Increased IL-33 expression in chronic obstructive pulmonary disease","volume":"308","author":"Xia","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jaip.2024.03.010_bib38","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.39905","article-title":"IgE-mediated mast cell activation promotes inflammation and cartilage destruction in osteoarthritis","volume":"8","author":"Wang","year":"2019","journal-title":"Elife"},{"issue":"Suppl 1","key":"10.1016\/j.jaip.2024.03.010_bib39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0090-4295(01)01129-3","article-title":"Mast cell involvement in interstitial cystitis: a review of human and experimental evidence","volume":"57","author":"Theoharides","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.jaip.2024.03.010_bib40","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s40478-021-01241-3","article-title":"The pathogenic role of c-Kit+ mast cells in the spinal motor neuron-vascular niche in ALS","volume":"9","author":"Kovacs","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.jaip.2024.03.010_bib41","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.3390\/ijms22062983","article-title":"Response criteria in advanced systemic mastocytosis: evolution in the era of KIT inhibitors","volume":"22","author":"Shomali","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2024.03.010_bib42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41385-020-00336-9","article-title":"A\u00a0monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation","volume":"14","author":"Schanin","year":"2021","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib43","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaci.2007.10.004","article-title":"Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement","volume":"121","author":"Yokoi","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"S109","key":"10.1016\/j.jaip.2024.03.010_bib44","first-page":"1374","article-title":"A\u00a0Siglec-8 antibody reduces substance P-induced inflammation by inhibiting MRGPR-mediated mast cell activation","volume":"75","author":"Gebremeskel","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.03.010_bib45","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/s42003-022-04207-w","article-title":"Discovery of an agonistic Siglec-6 antibody that inhibits and reduces human mast cells","volume":"5","author":"Schanin","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.jaip.2024.03.010_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2022.12.526","article-title":"An agonistic monoclonal antibody against Siglec-6 broadly inhibits mast cell activation in transgenic mice","volume":"151","author":"Benet","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/cells10010019","article-title":"Discovery, function, and therapeutic targeting of Siglec-8","volume":"10","author":"Youngblood","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jaip.2024.03.010_bib49","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jaci.2021.12.772","article-title":"An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria","volume":"149","author":"Altrichter","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib51","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000464326","article-title":"Comparison of the performance of Skin Prick, immunoCAP, and ISAC tests in the diagnosis of patients with allergy","volume":"172","author":"Griffiths","year":"2017","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib52","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000501079","article-title":"Why the 20%\u00a0+ 2 tryptase formula is a diagnostic gold standard for severe systemic mast cell activation and mast cell activation syndrome","volume":"180","author":"Valent","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.iac.2021.09.007","article-title":"Anaphylaxis and mast cell disorders","volume":"42","author":"Gulen","year":"2022","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.03.010_bib54","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2024.03.010_bib55","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1056\/NEJMoa1513098","article-title":"Efficacy and safety of midostaurin in advanced systemic mastocytosis","volume":"374","author":"Gotlib","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.03.010_bib56","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1182\/bloodadvances.2022007539","article-title":"Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis","volume":"6","author":"Reiter","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaip.2024.03.010_bib57","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0140-6736(16)31403-9","article-title":"Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study","volume":"389","author":"Lortholary","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.03.010_bib58","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1007\/s00432-015-1988-0","article-title":"Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study","volume":"141","author":"Hochhaus","year":"2015","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.jaip.2024.03.010_bib59","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/cncr.21996","article-title":"Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial","volume":"107","author":"Droogendijk","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jaip.2024.03.010_bib60","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000323763","article-title":"Clinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteria","volume":"156","author":"Valent","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib61","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jaip.2019.01.006","article-title":"Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome","volume":"7","author":"Valent","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.010_bib62","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaci.2021.02.013","article-title":"Mechanisms of human drug-induced anaphylaxis","volume":"147","author":"Bruhns","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib63","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.jaci.2015.04.019","article-title":"Platelets in the immune response: revisiting platelet-activating factor in anaphylaxis","volume":"135","author":"Gill","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib64","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000506199","article-title":"Elevated serum tryptase in non-anaphylaxis cases: a concise review","volume":"181","author":"Lee","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib65","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/cts.13163","article-title":"Dose-dependent inactivation of airway tryptase with a novel dissociating anti-tryptase antibody (MTPS9579A) in healthy participants: a randomized trial","volume":"15","author":"Rymut","year":"2022","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jaip.2024.03.010_bib66","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126219","article-title":"Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis","volume":"4","author":"Youngblood","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaip.2024.03.010_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.732209","article-title":"Serum CD203c+ extracellular vesicle serves as a novel diagnostic and prognostic biomarker for succinylated gelatin induced perioperative hypersensitive reaction","volume":"12","author":"Qi","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib68","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1164\/rccm.201002-0295OC","article-title":"Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program","volume":"183","author":"Balzar","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2024.03.010_bib69","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jaci.2010.03.003","article-title":"Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma","volume":"125","author":"Dougherty","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abb7221","article-title":"Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation","volume":"6","author":"Dwyer","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib71","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.jaci.2022.02.025","article-title":"Single-cell RNA sequencing of mast cells in eosinophilic esophagitis reveals heterogeneity, local proliferation, and activation that persists in remission","volume":"149","author":"Ben-Baruch Morgenstern","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.jaip.2024.03.010_bib72","article-title":"287 Targeting the inhibitory receptor Siglec-8 on mast cells represents an attractive approach to reduce MRGPRX2-mediated mast cell activation","volume":"188","author":"Benet","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2024.03.010_bib73","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41586-020-03118-2","article-title":"Local immune response to food antigens drives meal-induced abdominal pain","volume":"590","author":"Aguilera-Lizarraga","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2024.03.010_bib74","doi-asserted-by":"crossref","first-page":"11939","DOI":"10.1016\/S0021-9258(19)68496-6","article-title":"Tryptase from human pulmonary mast cells. Purification and characterization","volume":"256","author":"Schwartz","year":"1981","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaip.2024.03.010_bib75","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1586\/17474086.2014.955008","article-title":"The serum tryptase test: an emerging robust biomarker in clinical hematology","volume":"7","author":"Valent","year":"2014","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jaip.2024.03.010_bib76","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.4155\/bio-2020-0182","article-title":"Development of a specific immunoassay to selectively measure active tryptase in airway samples","volume":"12","author":"Sperinde","year":"2020","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jaip.2024.03.010_bib77","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00018-010-0587-0","article-title":"Biological implications of preformed mast cell mediators","volume":"68","author":"Lundequist","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaip.2024.03.010_bib78","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/imr.12639","article-title":"Biomarkers for evaluation of mast cell and basophil activation","volume":"282","author":"Kabashima","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaip.2024.03.010_bib79","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1046\/j.1537-2995.1984.24685066810.x","article-title":"Histamine levels in stored human blood","volume":"24","author":"Frewin","year":"1984","journal-title":"Transfusion"},{"key":"10.1016\/j.jaip.2024.03.010_bib80","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF01980899","article-title":"Plasma histamine and clinical tolerance to infused histamine in normal, atopic and urticarial subjects","volume":"32","author":"Pollock","year":"1991","journal-title":"Agents Actions"},{"key":"10.1016\/j.jaip.2024.03.010_bib81","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jaip.2020.02.021","article-title":"The utility of measuring urinary metabolites of mast cell mediators in systemic mastocytosis and mast cell activation syndrome","volume":"8","author":"Butterfield","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.010_bib82","first-page":"2348","article-title":"Mast cell activation syndromes\u2014evaluation of current diagnostic criteria and laboratory tools in clinical practice (review)","volume":"20","author":"Leru","year":"2020","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jaip.2024.03.010_bib83","article-title":"Regulation of plasma histamine levels by the mast cell clock and its modulation by stress","volume":"7","author":"Nakamura","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2024.03.010_bib84","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000087571","article-title":"Eicosanoid mediators of mast cells: receptors, regulation of synthesis, and pathobiologic implications","volume":"87","author":"Boyce","year":"2005","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.jaip.2024.03.010_bib85","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/jlb.67.6.841","article-title":"Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis","volume":"67","author":"Malaviya","year":"2000","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jaip.2024.03.010_bib86","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/thx.2003.013573","article-title":"Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma","volume":"59","author":"Bochenek","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2024.03.010_bib87","doi-asserted-by":"crossref","first-page":"11712","DOI":"10.1073\/pnas.0701700104","article-title":"Chemotactic action of prostaglandin E2 on mouse mast cells acting via the PGE2 receptor 3","volume":"104","author":"Weller","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2024.03.010_bib88","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF03168446","article-title":"Role of histamine and platelet-activating factor in allergic rhinitis","volume":"60","author":"Alfaro","year":"2004","journal-title":"J\u00a0Physiol Biochem"},{"key":"10.1016\/j.jaip.2024.03.010_bib89","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaci.2012.08.016","article-title":"Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis","volume":"131","author":"Vadas","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib90","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1160\/TH11-05-0351","article-title":"Bleeding diathesis in patients with mast cell activation disease","volume":"106","author":"Seidel","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaip.2024.03.010_bib91","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.4049\/jimmunol.0900127","article-title":"Alpha 2-macroglobulin capture allows detection of mast cell chymase in serum and creates a reservoir of angiotensin II-generating activity","volume":"182","author":"Raymond","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.12.1523","article-title":"High serum levels of mast cell chymase and carboxypeptidase in mastocytosis","volume":"131","author":"Zhou","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib93","first-page":"814","article-title":"Measurement of plasma mast cell carboxypeptidase and chymase levels in children with allergic diseases [in Chinese]","volume":"13","author":"Pan","year":"2011","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"Suppl","key":"10.1016\/j.jaip.2024.03.010_bib94","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jaci.2007.05.001","article-title":"Risk assessment in anaphylaxis: current and future approaches","volume":"120","author":"Simons","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib95","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jaci.2018.01.043","article-title":"Mast cell activation test in the diagnosis of allergic disease and anaphylaxis","volume":"142","author":"Bahri","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib96","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.bja.2020.06.024","article-title":"Mast cell activation test in chlorhexidine allergy: a proof of concept","volume":"125","author":"Elst","year":"2020","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jaip.2024.03.010_bib97","series-title":"Plasma Siglec-6 as a potential new biomarker in systemic mastocytosis","author":"Teufelberger","year":"2023"},{"key":"10.1016\/j.jaip.2024.03.010_bib98","doi-asserted-by":"crossref","first-page":"7372","DOI":"10.1016\/S0021-9258(17)38401-6","article-title":"Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer","volume":"261","author":"Schwartz","year":"1986","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaip.2024.03.010_bib99","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/j.1742-4658.2006.05211.x","article-title":"Biology of mast cell tryptase. An inflammatory mediator","volume":"273","author":"Hallgren","year":"2006","journal-title":"FEBS J"},{"key":"10.1016\/j.jaip.2024.03.010_bib100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molimm.2014.04.001","article-title":"Human mast cell tryptase in biology and medicine","volume":"63","author":"Vitte","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib101","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.4049\/jimmunol.138.7.2184","article-title":"Evaluation of human peripheral blood leukocytes for mast cell tryptase","volume":"138","author":"Castells","year":"1987","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib102","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/j.jaip.2021.03.011","article-title":"Use and interpretation of acute and baseline tryptase in perioperative hypersensitivity and anaphylaxis","volume":"9","author":"Vitte","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.010_bib103","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/all.15032","article-title":"EAACI guidelines: anaphylaxis (2021 update)","volume":"77","author":"Muraro","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.03.010_bib104","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1182\/blood.V98.7.2200","article-title":"Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia","volume":"98","author":"Sperr","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2024.03.010_bib105","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","article-title":"A\u00a0novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib","volume":"103","author":"Akin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2024.03.010_bib106","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/all.15585","article-title":"Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria","volume":"78","author":"Terhorst-Molawi","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.03.010_bib107","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.206","article-title":"Acidic pH is essential for maintaining mast cell secretory granule homeostasis","volume":"8","author":"Pejler","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jaip.2024.03.010_bib108","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI118337","article-title":"The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis","volume":"96","author":"Schwartz","year":"1995","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2024.03.010_bib109","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2044.2004.03757.x","article-title":"Mast cell tryptase: a review of its physiology and clinical significance","volume":"59","author":"Payne","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jaip.2024.03.010_bib111","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.jaip.2023.08.008","article-title":"The normal range of baseline tryptase should be 1 to 15 ng\/mL and covers healthy individuals with H\u03b1T","volume":"11","author":"Valent","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.010_bib112","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1084\/jem.20190701","article-title":"Impact of naturally forming human alpha\/beta-tryptase heterotetramers in the pathogenesis of hereditary alpha-tryptasemia","volume":"216","author":"Le","year":"2019","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2024.03.010_bib113","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2024.03.010_bib114","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaci.2021.06.017","article-title":"Hereditary alpha tryptasemia is not associated with specific clinical phenotypes","volume":"149","author":"Chollet","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib115","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","article-title":"Hereditary alpha tryptasemia: genotyping and associated clinical features","volume":"38","author":"Lyons","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.03.010_bib116","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.2020006157","article-title":"Hereditary alpha tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis","volume":"137","author":"Greiner","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2024.03.010_bib117","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaci.2021.08.007","article-title":"Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis","volume":"149","author":"Mateja","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib118","first-page":"282","article-title":"Serum tryptase levels and markers of renal dysfunction in a population with chronic kidney disease","volume":"23","author":"Sirvent","year":"2010","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.jaip.2024.03.010_bib119","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1365-2362.2009.02184.x","article-title":"Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology","volume":"39","author":"Sperr","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jaip.2024.03.010_bib120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12948-015-0013-0","article-title":"Serum tryptase detected during acute coronary syndrome is significantly related to the development of major adverse cardiovascular events after 2 years","volume":"13","author":"Pastorello","year":"2015","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.jaip.2024.03.010_bib121","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"Alvarez-Twose","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib122","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2340\/00015555-1486","article-title":"The utility of serum tryptase as a marker in chronic spontaneous urticaria","volume":"93","author":"Siles","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2024.03.010_bib123","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1365-2222.2010.03582.x","article-title":"Serum total tryptase levels are increased in patients with active chronic urticaria","volume":"40","author":"Ferrer","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.03.010_bib124","doi-asserted-by":"crossref","first-page":"8985","DOI":"10.1038\/s41598-017-09361-4","article-title":"Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells","volume":"7","author":"Serrano-Candelas","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2024.03.010_bib125","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bjd\/ljad191","article-title":"Safety and efficacy of lirentelimab in patients with refractory indolent systemic mastocytosis: a first-in-human clinical trial","volume":"189","author":"Siebenhaar","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2024.03.010_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.650331","article-title":"Mast cell and eosinophil activation are associated with COVID-19 and TLR-mediated viral inflammation: implications for an anti-Siglec-8 antibody","volume":"12","author":"Gebremeskel","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib127","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/all.15188","article-title":"Mast cell activation is associated with post-acute COVID-19 syndrome","volume":"77","author":"Wechsler","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.03.010_bib128","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/cells8040334","article-title":"Flow cytometry-based characterization of mast cells in human atherosclerosis","volume":"8","author":"Kritikou","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jaip.2024.03.010_bib129","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0145-2126(02)00343-0","article-title":"Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma\/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI","volume":"27","author":"Kirshenbaum","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaip.2024.03.010_bib130","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jaci.2021.08.006","article-title":"A\u00a0novel functional mast cell assay for the detection of allergies","volume":"149","author":"Zbaren","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib131","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2147\/JAA.S237759","article-title":"The basophil activation test for clinical management of food allergies: recent advances and future directions","volume":"14","author":"Briceno Noriega","year":"2021","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.jaip.2024.03.010_bib132","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaci.2018.03.011","article-title":"A\u00a0novel human mast cell activation test for peanut allergy","volume":"142","author":"Santos","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib133","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1016\/j.jaip.2020.06.030","article-title":"Accurate diagnosis and prognosis in systemic mastocytosis: the role of mutational analysis","volume":"8","author":"Weiler","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.010_bib134","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00277-013-1964-1","article-title":"The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis","volume":"93","author":"Erben","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jaip.2024.03.010_bib135","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.156669","article-title":"Serological profiling reveals hsa-miR-451a as a possible biomarker of anaphylaxis","volume":"7","author":"Francuzik","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaip.2024.03.010_bib136","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1471-2164-7-210","article-title":"Genome-wide gene expression profiling of human mast cells stimulated by IgE or FcepsilonRI-aggregation reveals a complex network of genes involved in inflammatory responses","volume":"7","author":"Jayapal","year":"2006","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jaip.2024.03.010_bib137","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.4049\/jimmunol.1601825","article-title":"Transcriptional heterogeneity of mast cells and basophils upon activation","volume":"198","author":"Chhiba","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib138","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1053\/j.gastro.2009.07.005","article-title":"Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome","volume":"137","author":"Buhner","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2024.03.010_bib139","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib140","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.jaip.2023.02.017","article-title":"Increased excretion of mast cell mediator metabolites during mast cell activation syndrome","volume":"11","author":"Butterfield","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.010_bib141","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jaip.2017.07.001","article-title":"Diagnostic accuracy of urinary LTE4 measurement to predict aspirin-exacerbated respiratory disease in patients with asthma","volume":"6","author":"Bochenek","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.010_bib142","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jaci.2015.10.020","article-title":"Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease","volume":"137","author":"Buchheit","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.010_bib143","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.alit.2023.05.003","article-title":"Chronic urticaria and the pathogenic role of mast cells","volume":"72","author":"Elieh-Ali-Komi","year":"2023","journal-title":"Allergol Int"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321982400271X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321982400271X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T04:26:58Z","timestamp":1730521618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221321982400271X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":140,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S221321982400271X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.03.010","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detecting Changes in Mast Cell Numbers Versus Activation in Human Disease: A Roadblock for Current Biomarkers?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}